OLMEGAN

Swiss trademark · 476458 · Word mark · Deleted

Register entry

Registration number
476458
Application number
02118/2000
Status
Deleted
Type
Word mark
Filed
Feb 24, 2000
Registered
Aug 24, 2000
Published
Oct 19, 2000
Deleted
Sep 27, 2010
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Olmesartan medoxomil und Olmesartan medoxomil/hydrochlorothiazide für die Behandlung von kardiovasculären Erkrankungen inklusive Bluthochdruck, kongestive Herzinsuffizienz, diabetische Nephropathie, Arteriosklerose und Schlaganfall (Angiotensin II Rezeptor Antagonis).

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 19, 2024

    Publication

    Published in Swissreg on 19.11.2024

  2. Sep 27, 2010

    Deleted, not renewed

    Published in Swissreg on 27.09.2010

  3. May 13, 2002

    Partly deleted

    LGS
    5, Pharmazeutische Präparate und Substanzen. → 5, Olmesartan medoxomil und Olmesartan medoxomil/hydrochlorothiazide für die Behandlung von kardiovasculären Erkrankungen inklusive Bluthochdruck, kongestive Herzinsuffizienz, diabetische Nephropathie, Arteriosklerose und Schlaganfall (Angiotensin II Rezeptor Antagonis).
    International classification
    5 → 5

    Published in the SOGC no. 90 of 13.05.2002

  4. Oct 19, 2000

    Registered

    Published in the SOGC no. 204 of 19.10.2000

Parties

Holder

Sankyo Company Limited

5-1, Nihonbashi Honcho 3-chome Chuo-ku, Tokyo, JP

Agent

A. W. Metz & Co. AG in Liquidation

A.W. Metz & Co. AG

Hottingerstrasse 14, 8024 Zürich

In liquidation

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.